InsiderClue
Stocks · Technology · Services-Prepackaged Software

BiomX Inc.

PHGE Clue Score33
United States Fiscal year ends December CIK 0001739174
Alert on the numbers Alert on insider trades

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Net income
$36.20M
Free cash flow
$26.39M
Return on capital
-692.6%
EPS growth, 1 yr
-61.9%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -30M FY20 Fiscal year 2020 Revenue $0.00 Net income $30.09M Margin n/a 0K -36M FY21 Fiscal year 2021 Revenue $0.00 Net income $36.23M Margin n/a 0K -28M FY22 Fiscal year 2022 Revenue $0.00 Net income $28.32M Margin n/a 0K -26M FY23 Fiscal year 2023 Revenue $0.00 Net income $26.17M Margin n/a 0K -18M FY24 Fiscal year 2024 Revenue $0.00 Net income $17.73M Margin n/a 0K -36M FY25 Fiscal year 2025 Revenue $0.00 Net income $36.20M Margin n/a
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
17 Mar 2026 Yeganeh Reuven
Director
 Sold at will $2.65M 100%
16 Mar 2026 Yeganeh Reuven
Director
 Sold at will $2.25M 100%
13 Mar 2026 Yeganeh Reuven
Director
 Sold at will $1.85M 100%
12 Mar 2026 Yeganeh Reuven
Director
 Sold at will $1.50M 100%
15 May 2024 OrbiMed Israel BioFund GP Limited Partnership
10% owner
 Sold at will $9.28K 0.2%
29 Nov 2023 Oron Assaf
Chief Business Officer
 Sold at will $4.07K 100%